Temasek Holdings (Private) LTD Biomarin Pharmaceutical Inc Transaction History

Temasek Holdings (Private) LTD

  • $21.4 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$79.55 - $124.22 $189 Million - $295 Million
-2,372,712 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$93.92 - $105.72 $103 Million - $116 Million
-1,100,000 Reduced 31.68%
2,372,712 $230 Million
Q3 2017

Nov 14, 2017
BUY
$80.6 - $94.95 $280 Million - $330 Million
3,472,712
3,472,712 $323 Million

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Temasek Holdings (Private) LTD Portfolio

Follow Temasek Holdings (Private) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Temasek Holdings (Private) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Temasek Holdings (Private) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email